Express Scripts (ESRX)

ESRX (NASDAQ:Health Services)
$72.29
neg -0.89
-1.22%
Today's Range: 72.10 - 73.50 | ESRX Avg Daily Volume: 5,382,400
Last Update: 04/17/14 - 4:00 PM EDT
Volume: 5,336,958
YTD Performance: 2.92%
Open: $73.28
Previous Close: $73.18
52 Week Range: $54.90 - $79.37
Oustanding Shares: 776,032,000
Market Cap: 56,751,995,676
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 13 11 11
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.50 1.56 1.56
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 33.36
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
33.36 32.70 29.01
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.81% 30.02% 30.39%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 1.31 0.32
Net Income 40.80 0.60 0.17
EPS 28.00 0.04 0.01
Earnings for ESRX:
EBITDA 6.00B
Revenue 104.10B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $1.01 $1.27 $4.95 $5.62
Number of Analysts 16 15 18 17
High Estimate $1.05 $1.37 $5.05 $5.80
Low Estimate $0.99 $1.20 $4.85 $5.50
Prior Year $0.99 $1.11 $4.33 $4.95
Growth Rate (Year over Year) 1.70% 14.41% 14.25% 13.68%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Nov 07, 2012 | 9:04 AM EST
Shares of ESRX now seen reaching $60, Oppenheimer said. Estimates also lowered on utilization headwinds. Outperform rating.
Bearish
Nov 07, 2012 | 8:25 AM EST
Shares of ESRX now seen reaching $62, Citigroup said. Estimates also lowered after company pulls forward 2013 EPS. Neutral rating. ...
Company says next year's estimates look overly optimistic but they still expect another all-time record.

Putting ESRX Under the 'Scope Real Money Pro($)

It's still early in my analysis. 
Bearish
Nov 06, 2012 | 8:27 AM EST
Shares of ESRX downgraded to Hold from Buy, Jefferies said. $56 price target. Train slowing down.
Express Scripts tempers expectations, and EOG raises its growth forecast.

Contributor Ken Shreve takes a look at upcoming economic data and some key earnings reports for the week of Nov. 5

The stock is making a pre-breakout-type move and is set up well for continued upside.
Romney trusts some of his money with hedge fund managers Karsch, Brosens and Halvorsen.
Bullish
Aug 23, 2012 | 8:17 AM EDT
Shares of ESRX now seen reaching $70, Jefferies said. Estimates also raised on Medco synergies coming sooner. Buy rating.

Columnist Conversations

There were nice reversal-type candles on the weekly charts of the major indices. The DOW and the S&P forme...
A number of stocks on my watch lists are attempting to form positive candles a key support levels. I noted th...
Lang:
While last week was a day to pull the plug and contemplate where the market was headed, I waited for some conf...
Shares of TSLA have formed multiple hammer candles at a key level of support defined by: the September head an...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.